Valuation: Haleon plc

Market Cap 32.47B 43.65B 37.91B 35.21B 61.16B 4,167B 62.27B 417B 163B 2,070B 164B 160B 6,960B P/E 2026 *
19.2x
P/E 2027 * 17.2x
Enterprise Value 39.34B 52.88B 45.93B 42.65B 74.1B 5,048B 75.44B 505B 198B 2,507B 199B 194B 8,432B EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.27x
Free-Float
99.42%
Yield 2026 *
2.11%
Yield 2027 * 2.42%
1 day-2.92%
1 week+1.94%
Current month+6.01%
1 month+6.01%
3 months+8.41%
6 months-2.72%
Current year-1.65%
1 week 365.7
Extreme 365.7
384.2
1 month 351.83
Extreme 351.828
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.92%+1.94%+1.01%+9.38% 44.43B
-4.55%-2.61%+51.95%+151.91% 1,079B
-3.66%-1.33%+52.95%+46.62% 640B
-2.24%+0.19%+35.97%+70.64% 465B
-2.29%+1.12%+36.13%+31.18% 353B
-2.28%-0.69%+33.42%+40.48% 301B
-3.15%+0.25%+10.63%+15.03% 271B
-2.12%+3.31%+1.82%-37.38% 228B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 165B
Average -1.94%+4.73%+26.69%+46.27% 375.41B
Weighted average by Cap. -1.64%+4.85%+37.60%+72.14%

Financials

2026 *2027 *
Net sales 11.4B 15.33B 13.32B 12.37B 21.48B 1,464B 21.87B 146B 57.32B 727B 57.57B 56.31B 2,445B 11.89B 15.99B 13.89B 12.9B 22.4B 1,526B 22.81B 153B 59.78B 758B 60.04B 58.73B 2,550B
Net income 1.7B 2.29B 1.99B 1.85B 3.21B 218B 3.26B 21.85B 8.56B 109B 8.59B 8.41B 365B 1.91B 2.57B 2.23B 2.07B 3.6B 245B 3.66B 24.5B 9.59B 122B 9.64B 9.43B 409B
Net Debt 6.87B 9.23B 8.02B 7.45B 12.93B 881B 13.17B 88.15B 34.51B 438B 34.66B 33.91B 1,472B 6.4B 8.61B 7.48B 6.94B 12.06B 822B 12.28B 82.21B 32.19B 408B 32.33B 31.62B 1,373B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-30 GBX 368.60 -2.92% 27,282,182
26-07-29 GBX 379.70 -0.32% 36,335,259
26-07-28 GBX 380.90 +2.89% 29,790,922
26-07-27 GBX 370.20 +1.84% 24,375,691
26-07-24 GBX 363.50 +0.53% 12,865,658
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.686GBP
Average target price
4.151GBP
Spread / Average Target
+12.62%

Quarterly revenue - Rate of surprise